Showcasing its strength at CPHI, it has won global attention.

Recently, Hangzhou Thinheal Pharma-Tech Co., Ltd made a brilliant appearance at the CPHI Worldwide trade fair in Germany, attracting widespread attention from many international industry partners with its technological strength and solutions in the fields of peptides and innovative drugs.

During the exhibition, the Xinhai Pharmaceutical team engaged in in-depth exchanges with company representatives, experts, scholars, and potential clients from Europe, North America, Asia, and other regions. The interactive sessions were lively, and a series of fruitful discussions and photos not only captured moments of sincere cooperation but also laid a solid foundation for further expansion into international markets and the establishment of long-term partnerships.

At this exhibition, the company showcased its R&D and production capabilities in mature business segments such as customized peptides, pharmaceutical peptides, and cosmetic peptides, while also actively promoting its progress in cutting-edge areas such as peptide drugs and nuclear medicine. Leveraging its background as a national high-tech enterprise, its drug production license, and ISO quality management system certification, Xinhai Pharmaceutical demonstrated to the world its rigorous quality control standards and its technological strength in continuous innovation.

In the future, Xinhai Pharmaceuticals will continue to uphold an open and cooperative attitude, accelerate its internationalization strategy, and strive 

to become a trusted R&D and manufacturing partner in the global biopharmaceutical field.